Format

Send to

Choose Destination
CA Cancer J Clin. 1995 Mar-Apr;45(2):88-101.

The treatment of epithelial ovarian cancer.

Author information

1
Division of Hematology/Oncology, Emory University School of Medicine Atlanta, Georgia.

Abstract

The treatment and long-term survival of patients with ovarian cancer varies by stage. At present, five-year survival for patients with early-stage disease ranges from 50 to 95 percent, while five-year survival for patients with advanced-stage disease is less than 25 percent. Several new drugs with significant activity in advanced-stage ovarian cancer offer hope for increased long-term survival in the future. This article reviews the current and experimental approaches to the treatment of all stages of ovarian cancer.

Comment in

PMID:
7889393
DOI:
10.3322/canjclin.45.2.88
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center